About Us
Specializing in comprehensive diagnosis and treatment of gastrointestinal and liver conditions.
Dr. Juanda Leo Hartono specializes in the diagnosis and treatment of gastrointestinal and liver conditions. Our clinic is dedicated to providing top-quality care, utilizing advanced medical technology and personalized treatment plans to ensure the best outcomes for our patients. With a commitment to excellence and patient-centered care, we strive to address all aspects of gastrointestinal and liver health with professionalism and compassion.
Postgraduate Qualifications
M.Int.Med (Master of Internal Medicine), University of Malaya, Malaysia
MRCP (Member, Royal College of Physicians), UK
SCE (Specialty Certificate Exam) Gastro, UK
FRCP (Fellow, Royal College of Physicians), London
Language
English, Chinese, Bahasa Melayu, Bahasa Indonesia, Hokkien
About
Dr. Juanda Leo Hartono 梁光祖
Clinical Background / Experience
Dr. Juanda is an experienced senior consultant in gastroenterology & hepatology, currently practising at Mt. Elizabeth Hospital, Singapore. Upon completion of his postgraduate Master of Internal Medicine training in University Malaya (Malaysia) and acquiring MRCP(UK), he moved to National University Hospital (NUH) Singapore as registrar in 2010 and completed his gastroenterology & hepatology specialist training at the same hospital in 2014. He was granted the Academic Medicine Development Award by NUH for Inflammatory Bowel Disease and Colorectal Cancer and underwent one year advanced fellowship at The Royal London Hospital (London, UK), where he was also JAG (Joint Advisory Group on GI Endoscopy) (UK) certified endoscopist. During his time in NUH, he had served as Patient Safety Officer, Clinical Director, and the IBD lead in Division of Gastroenterology & Hepatology. After leaving for his own private clinic, he remains an active visiting senior consultant at NUH.
Academic Activities
Dr. Juanda was a core clinical faculty and Assistant Professor at YLL School of Medicine, National University of Singapore, having served as core tutor and regular clinical examiner. He was also a core faculty member of postgraduate specialist training in gastroenterology & hepatology and was a member of Singapore board specialist examination committee.
He actively served as faculty member in medical conferences as invited speaker, chairperson, and organizing committee. He was the course director and lead speaker for the annual NUH IBD Preceptorship which was well attended by overseas doctors.
Awards
- Quality Improvement Project Award, National University Hospital Singapore, 2014.
- Academic Medicine Development Award 2016, National University Hospital & Ministry of Health, Singapore.
- Value Driven Outcomes (VDO) Excellence Award 2020. National University Hospital, Singapore.
- Long Service Award. National University Hospital Singapore.
- Great Teacher Award. National University of Singapore. 2022/2023
Selected Publications:
- Hartono JL, Qua CS, Goh KL. Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus. Dig Dis Sci. 2011 Jan;56(1):90-6.
- Hilmi I, Hartono JL, Goh KL. Negative perception in those at highest risk–potential challenges in colorectal cancer screening in an urban asian population. Asian Pac J Cancer Prev. 2010;11(3):815-22
- Hartono JL, Mahadeva S, Goh KL. Anxiety and depression in various functional gastrointestinal disorders: do differences exist? Journal of Digestive Diseases. 2012; 13(5):252-7
- Hartono JL, Aung MO, Dan YY, Gowans M, Lim K, Lee YM, Lee GH, Low HC, Tan PS, Thwin MA, Soon C, Chiu L-L, Khoo MJ, Koay E, Lim SG. Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 2013; 37(7):710-9.
- Hilmi I, Hartono JL, Pailoor J, Mahadeva S, Goh KL. Low prevalence of ‘classical’ microscopic colitis but evidence of microscopic inflammation in Asian Irritable Bowel Syndrome patients with diarrhea. BMC Gastroenterology. 2013; 13(1):80
- Ong DE, Kamm MA, Hartono JL, Lust M. Addition of Thiopurines Can Recapture Response in Patients with Crohn’s Disease who Have Lost Response to Anti-Tnf Monotherapy. J Gastroenterol Hepatol. 2013 ;28(10):1595-9
- Goh KL, Razlan H, Hartono JL, Qua CS, Yoong BK, Koh PS, Abdullah BJ. Liver Cancer in Malaysia: Epidemiology and Clinical Presentation in A Multiracial Asian Population. J Dig Dis. 2014
- Hartono JL, Koh T, Lee GH, Tan PS, Muthiah M, Aw MM, Madhavan K, Kow A, Lim KBL. Predictors of Non-adherence to Immunosuppressive Therapy in Asian Liver Transplant Recipients. Transplant Proc. 2017 Jul – Aug;49(6):1419-1424
- Chang PE, Hartono JL, Ngai YL, Dan YY, Lim KB, Chow WC. Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore. Singapore Med J. 2018 Dec 17
- Mak JWY, Tang W, Yip TCF, Ran ZH, Wei SC, Ahuja V, Kumar S, Leung WK, Hilmi I, Limsrivilai J, Aniwan S, Lam BCY, Chan KH, Ng KM, Leung CM, Li MKK, Lo FH, Sze ASF, Tsan SWC, Hui AJ, Hartono JL, Ng SC. Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn’s disease. Aliment Pharmacol Ther. 2019;50(11-12):1195‐
- Lee GH, Phyo WW, Loo WM, Kwok R, Ahmed T, Shabbir A, So J, Koh CJ, Hartono JL, Muthiah M, Lim K, Tan PS, Lee YM, Lim SG, Dan YY. Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population. World J Hepatol. 2020 Dec 27; 12(12):1228-38.
- Lee PY, Oen KQX, Lim GRS, Hartono JL, Muthiah M, Huang DQ, Teo FSW, Li AY, Mak A, Chandran NS, Tan CL, Yang P, Tai ES, Ng KWP, Vijayan J, Chan YC, Tan LL, Lee MB, Chua HR, Hong WZ, Yap ES, Lim DK, Yuen YS, Chan YH, Aminkeng F, Wong ASC, Huang Y, Tay SH. Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study. Cancers (Basel). 2021 Mar 15;13(6):1308
- Curtius K, Kabir M, Al Bakir I, Choi CHR, Hartono JL, Johnson M, East JE; Oxford IBD Cohort Study Investigators, Lindsay JO, Vega R, Thomas-Gibson S, Warusavitarne J, Wilson A, Graham TA, Hart A. Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool. Gut. 2021 May 14:gutjnl-2020-323546.
- Buie MJ, Quan J, Windsor JW, Coward S, Hansen TM, King JA, Kotze PG, Gearry RB, Ng SC, Mak JWY, Abreu MT, Rubin DT, Bernstein CN, Banerjee R, Yamamoto-Furusho JK, Panaccione R, Seow CH, Ma C, Underwood FE, Ahuja V, Panaccione N, Shaheen AA, Holroyd-Leduc J, Kaplan GG; Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group; Balderramo D, Chong VH, Juliao-Baños F, Dutta U, Simadibrata M, Kaibullayeva J, Sun Y, Hilmi I, Raja Ali RA, Paudel MS, Altuwaijri M, Hartono JL, Wei SC, Limsrivilai J, El Ouali S, Vergara BI, Dao VH, Kelly P, Hodges P, Miao Y, Li M. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses. Clin Gastroenterol Hepatol. 2022 Jul 19:S1542-3565(22)00670-X.
- Hu S, Mok J, Gowans M, Ong DEH, Hartono JL, Lee JWJ. Oral Microbiome of Crohn’s Disease Patients With and Without Oral Manifestations. J Crohns Colitis. 2022 Nov 1;16(10):1628-1636.
- Tan CQL, Loh GYW, Benjamin TWR, Koh CJ, Mok JSR, Hartono JL, Chua KTC, Tan HH, Siah KTH. Dental trauma in endoscopy: A systematic review and experience of a tertiary endoscopy centre. World J Gastrointest Endosc 2023 Aug 16;15(8):518-527.